gov identifier: NCT01930188) was a 56-week, randomised, double- blind, double-dummy, active-controlled, parallel-group trial in patients with type 2 diabetes inadequately controlled on metformin, thiazolidinediones, or both randomly assigned of treatment using semaglutide 0.5 mg plus sitagliptin 100 mg placebo, semaglutide 1.0 mg plus sitagliptin 100 mg placebo, sitagliptin 100 mg plus semaglutide 0.5 mg placebo, or sitagliptin 100 mg plus semaglutide 1.0 mg placebo
Subscription pricing for a two-month supply is $89.96 (10% off)
When comparing options, many patients weigh Mounjaro indications against their individual health goals, medical history, and what their insurance will approve
This antioxidant successfully reduces silver nitrite during the 72 h in the 60C (Figure 2)
Nature 444, 875880
2009 Jan;276(1):58-75